China National Medicines Corporation Ltd. (SHA: 600511)
China flag China · Delayed Price · Currency is CNY
34.42
-0.70 (-1.99%)
Nov 13, 2024, 3:00 PM CST

China National Medicines Corporation Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
51,09149,59245,43646,44240,33644,551
Upgrade
Other Revenue
103.99103.9962.9526.2643.0493.71
Upgrade
Revenue
51,19549,69645,49946,46940,37944,644
Upgrade
Revenue Growth (YoY)
7.81%9.23%-2.09%15.08%-9.56%15.24%
Upgrade
Cost of Revenue
47,36245,70441,68142,84837,24240,737
Upgrade
Gross Profit
3,8333,9923,8173,6213,1363,908
Upgrade
Selling, General & Admin
1,3321,4301,3921,3551,4041,473
Upgrade
Research & Development
62.1771.26755.7551.8744.93
Upgrade
Other Operating Expenses
132.53109.6946.91120.86105.54104.36
Upgrade
Operating Expenses
1,5321,6181,4981,5661,5711,639
Upgrade
Operating Income
2,3012,3742,3192,0551,5662,269
Upgrade
Interest Expense
-20.68-31.57-26.88-43.71-56.81-48.46
Upgrade
Interest & Investment Income
586.42525.32362.42354.09279.16157.48
Upgrade
Currency Exchange Gain (Loss)
0.550.55-1.652.711.57-1.36
Upgrade
Other Non Operating Income (Expenses)
5.24-10.47-43.29-182.24-6.95
Upgrade
EBT Excluding Unusual Items
2,8722,8582,6092,3501,7922,370
Upgrade
Gain (Loss) on Sale of Investments
-23.9110.82----
Upgrade
Gain (Loss) on Sale of Assets
-0.390.081.68-0.070.07-0.53
Upgrade
Other Unusual Items
47.9962.4476.995.08125.457.25
Upgrade
Pretax Income
2,9112,9312,6882,4451,9172,427
Upgrade
Income Tax Expense
583.18596.42559.18516.3408.09546.08
Upgrade
Earnings From Continuing Operations
2,3272,3342,1291,9291,5091,880
Upgrade
Minority Interest in Earnings
-162.51-188.47-164.65-174.42-126.56-276.58
Upgrade
Net Income
2,1652,1461,9641,7541,3831,604
Upgrade
Net Income to Common
2,1652,1461,9641,7541,3831,604
Upgrade
Net Income Growth
8.54%9.26%11.97%26.86%-13.79%14.23%
Upgrade
Shares Outstanding (Basic)
755754755755754762
Upgrade
Shares Outstanding (Diluted)
755754755755754762
Upgrade
Shares Change (YoY)
0.00%-0.00%-0.00%0.00%-0.98%-0.62%
Upgrade
EPS (Basic)
2.872.842.602.321.832.10
Upgrade
EPS (Diluted)
2.872.842.602.321.832.10
Upgrade
EPS Growth
8.53%9.27%11.97%26.86%-12.94%14.95%
Upgrade
Free Cash Flow
1,5402,5822,2651,8621,2331,690
Upgrade
Free Cash Flow Per Share
2.043.423.002.471.632.22
Upgrade
Dividend Per Share
0.8540.8540.7820.7000.5500.638
Upgrade
Dividend Growth
9.21%9.21%11.71%27.27%-13.79%59.50%
Upgrade
Gross Margin
7.49%8.03%8.39%7.79%7.77%8.75%
Upgrade
Operating Margin
4.49%4.78%5.10%4.42%3.88%5.08%
Upgrade
Profit Margin
4.23%4.32%4.32%3.77%3.42%3.59%
Upgrade
Free Cash Flow Margin
3.01%5.19%4.98%4.01%3.05%3.79%
Upgrade
EBITDA
2,4092,4802,4232,1551,6692,368
Upgrade
EBITDA Margin
4.70%4.99%5.32%4.64%4.13%5.30%
Upgrade
D&A For EBITDA
107.88106.15103.86100.1103.4698.42
Upgrade
EBIT
2,3012,3742,3192,0551,5662,269
Upgrade
EBIT Margin
4.49%4.78%5.10%4.42%3.88%5.08%
Upgrade
Effective Tax Rate
20.04%20.35%20.80%21.12%21.28%22.50%
Upgrade
Revenue as Reported
51,19549,69645,49946,46940,37944,644
Upgrade
Advertising Expenses
-6.73.252.253.26.91
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.